TREVENTIS Corporation
Latest round
- Seed
Last raised
- Aug 2009
Total raised
- $0.6M
Investors
- 1
About TREVENTIS Corporation
TREVENTIS Corporation focuses on developing pharmaceutical compounds that address misfolded proteins, which are linked to neurodegenerative diseases.TREVENTIS Corporation was founded in 2008 in the US and specializes in the creation of pharmaceutical solutions for neurodegenerative diseases. The company was established by Christopher Barden, Donald Weaver, L. McIntosh, and William Wong.4 mn from Wellcome Trust.TREVENTIS Corporation specializes in designing and developing pharmaceutical compounds that target misfolded proteins, a significant factor in neurodegenerative diseases. Their proprietary Common Conformational Morphology (CCM) technology is essential for identifying druggable active sites in these proteins, allowing the rational design of small molecules aimed at treating conditions like Alzheimer's disease.TREVENTIS Corporation generates revenue through strategic partnerships, particularly with prominent pharmaceutical companies such as Takeda.4 mn from Wellcome Trust, aimed at supporting the advancement of their drug development initiatives. Future growth plans involve designing and launching new pharmaceutical products targeting misfolded proteins and expanding market presence in North America and Europe by targeting pharmaceutical companies and research institutions.
Who invested in TREVENTIS Corporation
1 investor across 1 round
See all investors in TREVENTIS Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 10, 2009
Amount
$0.6M
Investors
Questions about TREVENTIS Corporation
Who invested in TREVENTIS Corporation?
TREVENTIS Corporation has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TREVENTIS Corporation raised?
TREVENTIS Corporation has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did TREVENTIS Corporation last raise money?
TREVENTIS Corporation's most recent round on record is a Seed, in Aug 2009.
What does TREVENTIS Corporation do?
TREVENTIS Corporation focuses on developing pharmaceutical compounds that address misfolded proteins, which are linked to neurodegenerative diseases.
Where is TREVENTIS Corporation headquartered?
TREVENTIS Corporation is headquartered in US.
Which VCs invest in companies like TREVENTIS Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at TREVENTIS Corporation's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like TREVENTIS Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.